Eva

Eva Pharma is a leading multinational pharmaceutical company headquartered in Egypt, recognized as one of the fastest-growing healthcare entities in the Middle East and Africa. The company operates state-of-the-art manufacturing facilities and the Mounir Armanious Research Center (MARC), focusing on a diverse portfolio of over 300 products across various therapeutic areas such as neurology, psychiatry, cardiovascular, and diabetes. Eva Pharma has gained international prominence through strategic licensing agreements with global giants like Gilead Sciences for the production of COVID-19 treatments and Eli Lilly for the localized manufacturing of insulin. With a presence in more than 40 countries, the company plays a critical role in increasing access to essential medicines in emerging markets.